Pharmacogenomic testing in children with complex medical histories can help predict and prevent adverse drug reactions, improve adherence and salvage drugs with high toxicity.
The tests yield actionable results in most cases, acording to Shannon Manzi, PharmD, BCCPS, the former director of the clinical pharmacogenomics service at Boston Children’s Hospital (BCH). “More than 92% of patients tested by the BCH service” received such results, she said.
Cystic fibrosis